Market Intelligence chevron_right Medical Care chevron_right Veterinary Active Pharmaceutical Ingredients Manufacturing
Global Report 2025

Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Growth (Status and Outlook) 2025-2031

calendar_todayPublished: Jun 2025 descriptionPages: 126 categoryCategory: Medical Care
cloud_downloadRequest Sample Report
mailPre-Order Enquiry
local_offerGet Discount 
1 Scope of the Report
 1.1 Market Introduction
 1.2 Years Considered
 1.3 Research Objectives
 1.4 Market Research Methodology
 1.5 Research Process and Data Source
 1.6 Economic Indicators
 1.7 Currency Considered
 1.8 Market Estimation Caveats
2 Executive Summary
 2.1 World Market Overview
 2.1.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size (2020-2031)
 2.1.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size CAGR by Region (2020 VS 2024 VS 2031)
 2.1.3 World Current & Future Analysis for Veterinary Active Pharmaceutical Ingredients Manufacturing by Country/Region (2020, 2024 & 2031)
 2.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Segment by Type
 2.2.1 Antiparasitic
 2.2.2 Anti-infectives
 2.2.3 NSAIDs
 2.2.4 Others
 2.3 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Type
 2.3.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size CAGR by Type (2020 VS 2024 VS 2031)
 2.3.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share by Type (2020-2025)
 2.4 Veterinary Active Pharmaceutical Ingredients Manufacturing Segment by Application
 2.4.1 Companion Animals
 2.4.2 Production/Food Animals
 2.5 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Application
 2.5.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size CAGR by Application (2020 VS 2024 VS 2031)
 2.5.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share by Application (2020-2025)
3 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Player
 3.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share by Player
 3.1.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Player (2020-2025)
 3.1.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Player (2020-2025)
 3.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Key Players Head office and Products Offered
 3.3 Market Concentration Rate Analysis
 3.3.1 Competition Landscape Analysis
 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 3.4 New Products and Potential Entrants
 3.5 Mergers & Acquisitions, Expansion
4 Veterinary Active Pharmaceutical Ingredients Manufacturing by Region
 4.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Region (2020-2025)
 4.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Annual Revenue by Country/Region (2020-2025)
 4.3 Americas Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth (2020-2025)
 4.4 APAC Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth (2020-2025)
 4.5 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth (2020-2025)
 4.6 Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth (2020-2025)
5 Americas
 5.1 Americas Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2020-2025)
 5.2 Americas Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Type (2020-2025)
 5.3 Americas Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Application (2020-2025)
 5.4 United States
 5.5 Canada
 5.6 Mexico
 5.7 Brazil
6 APAC
 6.1 APAC Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Region (2020-2025)
 6.2 APAC Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Type (2020-2025)
 6.3 APAC Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Application (2020-2025)
 6.4 China
 6.5 Japan
 6.6 South Korea
 6.7 Southeast Asia
 6.8 India
 6.9 Australia
7 Europe
 7.1 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2020-2025)
 7.2 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Type (2020-2025)
 7.3 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Application (2020-2025)
 7.4 Germany
 7.5 France
 7.6 UK
 7.7 Italy
 7.8 Russia
8 Middle East & Africa
 8.1 Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing by Region (2020-2025)
 8.2 Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Type (2020-2025)
 8.3 Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Application (2020-2025)
 8.4 Egypt
 8.5 South Africa
 8.6 Israel
 8.7 Turkey
 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
 9.1 Market Drivers & Growth Opportunities
 9.2 Market Challenges & Risks
 9.3 Industry Trends
10 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Forecast
 10.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast by Region (2026-2031)
 10.1.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast by Region (2026-2031)
 10.1.2 Americas Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast
 10.1.3 APAC Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast
 10.1.4 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast
 10.1.5 Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast
 10.2 Americas Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast by Country (2026-2031)
 10.2.1 United States Market Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast
 10.2.2 Canada Market Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast
 10.2.3 Mexico Market Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast
 10.2.4 Brazil Market Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast
 10.3 APAC Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast by Region (2026-2031)
 10.3.1 China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Forecast
 10.3.2 Japan Market Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast
 10.3.3 Korea Market Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast
 10.3.4 Southeast Asia Market Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast
 10.3.5 India Market Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast
 10.3.6 Australia Market Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast
 10.4 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast by Country (2026-2031)
 10.4.1 Germany Market Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast
 10.4.2 France Market Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast
 10.4.3 UK Market Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast
 10.4.4 Italy Market Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast
 10.4.5 Russia Market Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast
 10.5 Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast by Region (2026-2031)
 10.5.1 Egypt Market Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast
 10.5.2 South Africa Market Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast
 10.5.3 Israel Market Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast
 10.5.4 Turkey Market Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast
 10.6 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast by Type (2026-2031)
 10.7 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast by Application (2026-2031)
 10.7.1 GCC Countries Market Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast
11 Key Players Analysis
 11.1 Alivira Animal Health Ltd.
 11.1.1 Alivira Animal Health Ltd. Company Information
 11.1.2 Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 11.1.3 Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
 11.1.4 Alivira Animal Health Ltd. Main Business Overview
 11.1.5 Alivira Animal Health Ltd. Latest Developments
 11.2 Chempro Pharma Private Ltd.
 11.2.1 Chempro Pharma Private Ltd. Company Information
 11.2.2 Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 11.2.3 Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
 11.2.4 Chempro Pharma Private Ltd. Main Business Overview
 11.2.5 Chempro Pharma Private Ltd. Latest Developments
 11.3 Excel Industries Ltd.
 11.3.1 Excel Industries Ltd. Company Information
 11.3.2 Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 11.3.3 Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
 11.3.4 Excel Industries Ltd. Main Business Overview
 11.3.5 Excel Industries Ltd. Latest Developments
 11.4 FIS - Fabbrica Italiana Sintetici S.p.A.
 11.4.1 FIS - Fabbrica Italiana Sintetici S.p.A. Company Information
 11.4.2 FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 11.4.3 FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
 11.4.4 FIS - Fabbrica Italiana Sintetici S.p.A. Main Business Overview
 11.4.5 FIS - Fabbrica Italiana Sintetici S.p.A. Latest Developments
 11.5 HIKAL Ltd.
 11.5.1 HIKAL Ltd. Company Information
 11.5.2 HIKAL Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 11.5.3 HIKAL Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
 11.5.4 HIKAL Ltd. Main Business Overview
 11.5.5 HIKAL Ltd. Latest Developments
 11.6 HuBei Masteam Bio-tech
 11.6.1 HuBei Masteam Bio-tech Company Information
 11.6.2 HuBei Masteam Bio-tech Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 11.6.3 HuBei Masteam Bio-tech Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
 11.6.4 HuBei Masteam Bio-tech Main Business Overview
 11.6.5 HuBei Masteam Bio-tech Latest Developments
 11.7 Hunan Huateng Pharmaceutical
 11.7.1 Hunan Huateng Pharmaceutical Company Information
 11.7.2 Hunan Huateng Pharmaceutical Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 11.7.3 Hunan Huateng Pharmaceutical Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
 11.7.4 Hunan Huateng Pharmaceutical Main Business Overview
 11.7.5 Hunan Huateng Pharmaceutical Latest Developments
 11.8 Jiangsu Rivocean
 11.8.1 Jiangsu Rivocean Company Information
 11.8.2 Jiangsu Rivocean Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 11.8.3 Jiangsu Rivocean Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
 11.8.4 Jiangsu Rivocean Main Business Overview
 11.8.5 Jiangsu Rivocean Latest Developments
 11.9 Ofichem Group
 11.9.1 Ofichem Group Company Information
 11.9.2 Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 11.9.3 Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
 11.9.4 Ofichem Group Main Business Overview
 11.9.5 Ofichem Group Latest Developments
 11.10 Qilu Pharma Spain, S.A.
 11.10.1 Qilu Pharma Spain, S.A. Company Information
 11.10.2 Qilu Pharma Spain, S.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 11.10.3 Qilu Pharma Spain, S.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
 11.10.4 Qilu Pharma Spain, S.A. Main Business Overview
 11.10.5 Qilu Pharma Spain, S.A. Latest Developments
 11.11 Menadiona
 11.11.1 Menadiona Company Information
 11.11.2 Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 11.11.3 Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
 11.11.4 Menadiona Main Business Overview
 11.11.5 Menadiona Latest Developments
 11.12 Nissan Chemical
 11.12.1 Nissan Chemical Company Information
 11.12.2 Nissan Chemical Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 11.12.3 Nissan Chemical Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
 11.12.4 Nissan Chemical Main Business Overview
 11.12.5 Nissan Chemical Latest Developments
 11.13 SUANFARMA
 11.13.1 SUANFARMA Company Information
 11.13.2 SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 11.13.3 SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
 11.13.4 SUANFARMA Main Business Overview
 11.13.5 SUANFARMA Latest Developments
 11.14 Siflon Drugs
 11.14.1 Siflon Drugs Company Information
 11.14.2 Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 11.14.3 Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
 11.14.4 Siflon Drugs Main Business Overview
 11.14.5 Siflon Drugs Latest Developments
 11.15 Shaanxi Dideu Group
 11.15.1 Shaanxi Dideu Group Company Information
 11.15.2 Shaanxi Dideu Group Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 11.15.3 Shaanxi Dideu Group Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
 11.15.4 Shaanxi Dideu Group Main Business Overview
 11.15.5 Shaanxi Dideu Group Latest Developments
 11.16 Taizhou Crene Biotechnology
 11.16.1 Taizhou Crene Biotechnology Company Information
 11.16.2 Taizhou Crene Biotechnology Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 11.16.3 Taizhou Crene Biotechnology Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
 11.16.4 Taizhou Crene Biotechnology Main Business Overview
 11.16.5 Taizhou Crene Biotechnology Latest Developments
 11.17 Zhejiang Gihi Chemicals
 11.17.1 Zhejiang Gihi Chemicals Company Information
 11.17.2 Zhejiang Gihi Chemicals Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 11.17.3 Zhejiang Gihi Chemicals Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
 11.17.4 Zhejiang Gihi Chemicals Main Business Overview
 11.17.5 Zhejiang Gihi Chemicals Latest Developments
 11.18 Vetpharma (Insud Pharma, S.L.U)
 11.18.1 Vetpharma (Insud Pharma, S.L.U) Company Information
 11.18.2 Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 11.18.3 Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
 11.18.4 Vetpharma (Insud Pharma, S.L.U) Main Business Overview
 11.18.5 Vetpharma (Insud Pharma, S.L.U) Latest Developments
12 Research Findings and Conclusion

List of Tables
 Table 1. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
 Table 2. Veterinary Active Pharmaceutical Ingredients Manufacturing Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Antiparasitic
 Table 4. Major Players of Anti-infectives
 Table 5. Major Players of NSAIDs
 Table 6. Major Players of Others
 Table 7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
 Table 8. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Type (2020-2025) & ($ millions)
 Table 9. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share by Type (2020-2025)
 Table 10. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
 Table 11. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Application (2020-2025) & ($ millions)
 Table 12. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share by Application (2020-2025)
 Table 13. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Player (2020-2025) & ($ millions)
 Table 14. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Player (2020-2025)
 Table 15. Veterinary Active Pharmaceutical Ingredients Manufacturing Key Players Head office and Products Offered
 Table 16. Veterinary Active Pharmaceutical Ingredients Manufacturing Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 17. New Products and Potential Entrants
 Table 18. Mergers & Acquisitions, Expansion
 Table 19. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Region (2020-2025) & ($ millions)
 Table 20. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share by Region (2020-2025)
 Table 21. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Country/Region (2020-2025) & ($ millions)
 Table 22. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Country/Region (2020-2025)
 Table 23. Americas Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2020-2025) & ($ millions)
 Table 24. Americas Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share by Country (2020-2025)
 Table 25. Americas Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Type (2020-2025) & ($ millions)
 Table 26. Americas Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share by Type (2020-2025)
 Table 27. Americas Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Application (2020-2025) & ($ millions)
 Table 28. Americas Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share by Application (2020-2025)
 Table 29. APAC Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Region (2020-2025) & ($ millions)
 Table 30. APAC Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share by Region (2020-2025)
 Table 31. APAC Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Type (2020-2025) & ($ millions)
 Table 32. APAC Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Application (2020-2025) & ($ millions)
 Table 33. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Country (2020-2025) & ($ millions)
 Table 34. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share by Country (2020-2025)
 Table 35. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Type (2020-2025) & ($ millions)
 Table 36. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Application (2020-2025) & ($ millions)
 Table 37. Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Region (2020-2025) & ($ millions)
 Table 38. Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Type (2020-2025) & ($ millions)
 Table 39. Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Application (2020-2025) & ($ millions)
 Table 40. Key Market Drivers & Growth Opportunities of Veterinary Active Pharmaceutical Ingredients Manufacturing
 Table 41. Key Market Challenges & Risks of Veterinary Active Pharmaceutical Ingredients Manufacturing
 Table 42. Key Industry Trends of Veterinary Active Pharmaceutical Ingredients Manufacturing
 Table 43. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Forecast by Region (2026-2031) & ($ millions)
 Table 44. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share Forecast by Region (2026-2031)
 Table 45. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Forecast by Type (2026-2031) & ($ millions)
 Table 46. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Forecast by Application (2026-2031) & ($ millions)
 Table 47. Alivira Animal Health Ltd. Details, Company Type, Veterinary Active Pharmaceutical Ingredients Manufacturing Area Served and Its Competitors
 Table 48. Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 Table 49. Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 50. Alivira Animal Health Ltd. Main Business
 Table 51. Alivira Animal Health Ltd. Latest Developments
 Table 52. Chempro Pharma Private Ltd. Details, Company Type, Veterinary Active Pharmaceutical Ingredients Manufacturing Area Served and Its Competitors
 Table 53. Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 Table 54. Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 55. Chempro Pharma Private Ltd. Main Business
 Table 56. Chempro Pharma Private Ltd. Latest Developments
 Table 57. Excel Industries Ltd. Details, Company Type, Veterinary Active Pharmaceutical Ingredients Manufacturing Area Served and Its Competitors
 Table 58. Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 Table 59. Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 60. Excel Industries Ltd. Main Business
 Table 61. Excel Industries Ltd. Latest Developments
 Table 62. FIS - Fabbrica Italiana Sintetici S.p.A. Details, Company Type, Veterinary Active Pharmaceutical Ingredients Manufacturing Area Served and Its Competitors
 Table 63. FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 Table 64. FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 65. FIS - Fabbrica Italiana Sintetici S.p.A. Main Business
 Table 66. FIS - Fabbrica Italiana Sintetici S.p.A. Latest Developments
 Table 67. HIKAL Ltd. Details, Company Type, Veterinary Active Pharmaceutical Ingredients Manufacturing Area Served and Its Competitors
 Table 68. HIKAL Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 Table 69. HIKAL Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 70. HIKAL Ltd. Main Business
 Table 71. HIKAL Ltd. Latest Developments
 Table 72. HuBei Masteam Bio-tech Details, Company Type, Veterinary Active Pharmaceutical Ingredients Manufacturing Area Served and Its Competitors
 Table 73. HuBei Masteam Bio-tech Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 Table 74. HuBei Masteam Bio-tech Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 75. HuBei Masteam Bio-tech Main Business
 Table 76. HuBei Masteam Bio-tech Latest Developments
 Table 77. Hunan Huateng Pharmaceutical Details, Company Type, Veterinary Active Pharmaceutical Ingredients Manufacturing Area Served and Its Competitors
 Table 78. Hunan Huateng Pharmaceutical Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 Table 79. Hunan Huateng Pharmaceutical Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 80. Hunan Huateng Pharmaceutical Main Business
 Table 81. Hunan Huateng Pharmaceutical Latest Developments
 Table 82. Jiangsu Rivocean Details, Company Type, Veterinary Active Pharmaceutical Ingredients Manufacturing Area Served and Its Competitors
 Table 83. Jiangsu Rivocean Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 Table 84. Jiangsu Rivocean Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 85. Jiangsu Rivocean Main Business
 Table 86. Jiangsu Rivocean Latest Developments
 Table 87. Ofichem Group Details, Company Type, Veterinary Active Pharmaceutical Ingredients Manufacturing Area Served and Its Competitors
 Table 88. Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 Table 89. Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 90. Ofichem Group Main Business
 Table 91. Ofichem Group Latest Developments
 Table 92. Qilu Pharma Spain, S.A. Details, Company Type, Veterinary Active Pharmaceutical Ingredients Manufacturing Area Served and Its Competitors
 Table 93. Qilu Pharma Spain, S.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 Table 94. Qilu Pharma Spain, S.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 95. Qilu Pharma Spain, S.A. Main Business
 Table 96. Qilu Pharma Spain, S.A. Latest Developments
 Table 97. Menadiona Details, Company Type, Veterinary Active Pharmaceutical Ingredients Manufacturing Area Served and Its Competitors
 Table 98. Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 Table 99. Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 100. Menadiona Main Business
 Table 101. Menadiona Latest Developments
 Table 102. Nissan Chemical Details, Company Type, Veterinary Active Pharmaceutical Ingredients Manufacturing Area Served and Its Competitors
 Table 103. Nissan Chemical Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 Table 104. Nissan Chemical Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 105. Nissan Chemical Main Business
 Table 106. Nissan Chemical Latest Developments
 Table 107. SUANFARMA Details, Company Type, Veterinary Active Pharmaceutical Ingredients Manufacturing Area Served and Its Competitors
 Table 108. SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 Table 109. SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 110. SUANFARMA Main Business
 Table 111. SUANFARMA Latest Developments
 Table 112. Siflon Drugs Details, Company Type, Veterinary Active Pharmaceutical Ingredients Manufacturing Area Served and Its Competitors
 Table 113. Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 Table 114. Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 115. Siflon Drugs Main Business
 Table 116. Siflon Drugs Latest Developments
 Table 117. Shaanxi Dideu Group Details, Company Type, Veterinary Active Pharmaceutical Ingredients Manufacturing Area Served and Its Competitors
 Table 118. Shaanxi Dideu Group Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 Table 119. Shaanxi Dideu Group Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 120. Shaanxi Dideu Group Main Business
 Table 121. Shaanxi Dideu Group Latest Developments
 Table 122. Taizhou Crene Biotechnology Details, Company Type, Veterinary Active Pharmaceutical Ingredients Manufacturing Area Served and Its Competitors
 Table 123. Taizhou Crene Biotechnology Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 Table 124. Taizhou Crene Biotechnology Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 125. Taizhou Crene Biotechnology Main Business
 Table 126. Taizhou Crene Biotechnology Latest Developments
 Table 127. Zhejiang Gihi Chemicals Details, Company Type, Veterinary Active Pharmaceutical Ingredients Manufacturing Area Served and Its Competitors
 Table 128. Zhejiang Gihi Chemicals Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 Table 129. Zhejiang Gihi Chemicals Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 130. Zhejiang Gihi Chemicals Main Business
 Table 131. Zhejiang Gihi Chemicals Latest Developments
 Table 132. Vetpharma (Insud Pharma, S.L.U) Details, Company Type, Veterinary Active Pharmaceutical Ingredients Manufacturing Area Served and Its Competitors
 Table 133. Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
 Table 134. Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 135. Vetpharma (Insud Pharma, S.L.U) Main Business
 Table 136. Vetpharma (Insud Pharma, S.L.U) Latest Developments


List of Figures
 Figure 1. Veterinary Active Pharmaceutical Ingredients Manufacturing Report Years Considered
 Figure 2. Research Objectives
 Figure 3. Research Methodology
 Figure 4. Research Process and Data Source
 Figure 5. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth Rate (2020-2031) ($ millions)
 Figure 6. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 7. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share by Country/Region (2024)
 Figure 8. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 9. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share by Type in 2024
 Figure 10. Veterinary Active Pharmaceutical Ingredients Manufacturing in Companion Animals
 Figure 11. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market: Companion Animals (2020-2025) & ($ millions)
 Figure 12. Veterinary Active Pharmaceutical Ingredients Manufacturing in Production/Food Animals
 Figure 13. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market: Production/Food Animals (2020-2025) & ($ millions)
 Figure 14. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share by Application in 2024
 Figure 15. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Market Share by Player in 2024
 Figure 16. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share by Region (2020-2025)
 Figure 17. Americas Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2020-2025 ($ millions)
 Figure 18. APAC Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2020-2025 ($ millions)
 Figure 19. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2020-2025 ($ millions)
 Figure 20. Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2020-2025 ($ millions)
 Figure 21. Americas Veterinary Active Pharmaceutical Ingredients Manufacturing Value Market Share by Country in 2024
 Figure 22. United States Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 23. Canada Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 24. Mexico Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 25. Brazil Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 26. APAC Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share by Region in 2024
 Figure 27. APAC Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share by Type (2020-2025)
 Figure 28. APAC Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share by Application (2020-2025)
 Figure 29. China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 30. Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 31. South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 32. Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 33. India Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 34. Australia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 35. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share by Country in 2024
 Figure 36. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share by Type (2020-2025)
 Figure 37. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share by Application (2020-2025)
 Figure 38. Germany Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 39. France Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 40. UK Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 41. Italy Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 42. Russia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 43. Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share by Region (2020-2025)
 Figure 44. Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share by Type (2020-2025)
 Figure 45. Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share by Application (2020-2025)
 Figure 46. Egypt Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 47. South Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 48. Israel Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 49. Turkey Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 50. GCC Countries Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth 2020-2025 ($ millions)
 Figure 51. Americas Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2026-2031 ($ millions)
 Figure 52. APAC Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2026-2031 ($ millions)
 Figure 53. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2026-2031 ($ millions)
 Figure 54. Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2026-2031 ($ millions)
 Figure 55. United States Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2026-2031 ($ millions)
 Figure 56. Canada Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2026-2031 ($ millions)
 Figure 57. Mexico Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2026-2031 ($ millions)
 Figure 58. Brazil Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2026-2031 ($ millions)
 Figure 59. China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2026-2031 ($ millions)
 Figure 60. Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2026-2031 ($ millions)
 Figure 61. Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2026-2031 ($ millions)
 Figure 62. Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2026-2031 ($ millions)
 Figure 63. India Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2026-2031 ($ millions)
 Figure 64. Australia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2026-2031 ($ millions)
 Figure 65. Germany Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2026-2031 ($ millions)
 Figure 66. France Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2026-2031 ($ millions)
 Figure 67. UK Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2026-2031 ($ millions)
 Figure 68. Italy Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2026-2031 ($ millions)
 Figure 69. Russia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2026-2031 ($ millions)
 Figure 70. Egypt Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2026-2031 ($ millions)
 Figure 71. South Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2026-2031 ($ millions)
 Figure 72. Israel Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2026-2031 ($ millions)
 Figure 73. Turkey Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2026-2031 ($ millions)
 Figure 74. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share Forecast by Type (2026-2031)
 Figure 75. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share Forecast by Application (2026-2031)
 Figure 76. GCC Countries Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size 2026-2031 ($ millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Alivira Animal Health Ltd.|||Chempro Pharma Private Ltd.|||Excel Industries Ltd.|||FIS - Fabbrica Italiana Sintetici S.p.A.|||HIKAL Ltd.|||HuBei Masteam Bio-tech|||Hunan Huateng Pharmaceutical|||Jiangsu Rivocean|||Ofichem Group|||Qilu Pharma Spain, S.A.|||Menadiona|||Nissan Chemical|||SUANFARMA|||Siflon Drugs|||Shaanxi Dideu Group|||Taizhou Crene Biotechnology|||Zhejiang Gihi Chemicals|||Vetpharma (Insud Pharma, S.L.U)

Frequently Asked Questions

What is the USP of the report? expand_more
Veterinary Active Pharmaceutical Ingredients Manufacturing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Veterinary Active Pharmaceutical Ingredients Manufacturing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Veterinary Active Pharmaceutical Ingredients Manufacturing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.